Alzheimer's disease

Lin, Yu-Hsuan, Hsu, Tien-Wei, Kao, Yu-Chen, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F, Stubbs, Brendon, Tseng, Ping-Tao, Hsu, Chih-Wei ORCID: https://orcid.org/0000-0002-8650-4060, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 and Tu, Yu-Kang (2026) Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry (JNNP). ISSN 0022-3050 (Print), 1468-330X (Online) (doi:10.1136/jnnp-2025-336691)

Hsu, Chih-Wei, Hsu, Tien-Wei ORCID: https://orcid.org/0000-0003-4136-1251, Kao, Yu-Chen, Lin, Yu-Hsuan, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F., Stubbs, Brendon, Tseng, Ping-Tao, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Tu, Yu-Kang ORCID: https://orcid.org/0000-0002-2461-474X and Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 (2025) The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis. The Journal of Prevention of Alzheimer's Disease:100195. ISSN 2426-0266 (Online) (doi:10.1016/j.tjpad.2025.100195)

Apolipoprotein E4

Lin, Yu-Hsuan, Hsu, Tien-Wei, Kao, Yu-Chen, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F, Stubbs, Brendon, Tseng, Ping-Tao, Hsu, Chih-Wei ORCID: https://orcid.org/0000-0002-8650-4060, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 and Tu, Yu-Kang (2026) Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry (JNNP). ISSN 0022-3050 (Print), 1468-330X (Online) (doi:10.1136/jnnp-2025-336691)

Hsu, Chih-Wei, Hsu, Tien-Wei ORCID: https://orcid.org/0000-0003-4136-1251, Kao, Yu-Chen, Lin, Yu-Hsuan, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F., Stubbs, Brendon, Tseng, Ping-Tao, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Tu, Yu-Kang ORCID: https://orcid.org/0000-0002-2461-474X and Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 (2025) The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis. The Journal of Prevention of Alzheimer's Disease:100195. ISSN 2426-0266 (Online) (doi:10.1016/j.tjpad.2025.100195)

cholinesterase inhibitors

Lin, Yu-Hsuan, Hsu, Tien-Wei, Kao, Yu-Chen, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F, Stubbs, Brendon, Tseng, Ping-Tao, Hsu, Chih-Wei ORCID: https://orcid.org/0000-0002-8650-4060, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 and Tu, Yu-Kang (2026) Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry (JNNP). ISSN 0022-3050 (Print), 1468-330X (Online) (doi:10.1136/jnnp-2025-336691)

Hsu, Chih-Wei, Hsu, Tien-Wei ORCID: https://orcid.org/0000-0003-4136-1251, Kao, Yu-Chen, Lin, Yu-Hsuan, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F., Stubbs, Brendon, Tseng, Ping-Tao, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Tu, Yu-Kang ORCID: https://orcid.org/0000-0002-2461-474X and Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 (2025) The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis. The Journal of Prevention of Alzheimer's Disease:100195. ISSN 2426-0266 (Online) (doi:10.1016/j.tjpad.2025.100195)

cognitive function

Lin, Yu-Hsuan, Hsu, Tien-Wei, Kao, Yu-Chen, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F, Stubbs, Brendon, Tseng, Ping-Tao, Hsu, Chih-Wei ORCID: https://orcid.org/0000-0002-8650-4060, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 and Tu, Yu-Kang (2026) Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry (JNNP). ISSN 0022-3050 (Print), 1468-330X (Online) (doi:10.1136/jnnp-2025-336691)

Hsu, Chih-Wei, Hsu, Tien-Wei ORCID: https://orcid.org/0000-0003-4136-1251, Kao, Yu-Chen, Lin, Yu-Hsuan, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F., Stubbs, Brendon, Tseng, Ping-Tao, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Tu, Yu-Kang ORCID: https://orcid.org/0000-0002-2461-474X and Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 (2025) The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis. The Journal of Prevention of Alzheimer's Disease:100195. ISSN 2426-0266 (Online) (doi:10.1016/j.tjpad.2025.100195)

monoclonal antibodies

Lin, Yu-Hsuan, Hsu, Tien-Wei, Kao, Yu-Chen, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F, Stubbs, Brendon, Tseng, Ping-Tao, Hsu, Chih-Wei ORCID: https://orcid.org/0000-0002-8650-4060, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 and Tu, Yu-Kang (2026) Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry (JNNP). ISSN 0022-3050 (Print), 1468-330X (Online) (doi:10.1136/jnnp-2025-336691)

Hsu, Chih-Wei, Hsu, Tien-Wei ORCID: https://orcid.org/0000-0003-4136-1251, Kao, Yu-Chen, Lin, Yu-Hsuan, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Carvalho, Andre F., Stubbs, Brendon, Tseng, Ping-Tao, Yang, Fu-Chi, Tsai, Chia-Kuang ORCID: https://orcid.org/0000-0001-7693-1408, Yu, Chia-Ling, Tu, Yu-Kang ORCID: https://orcid.org/0000-0002-2461-474X and Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 (2025) The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis. The Journal of Prevention of Alzheimer's Disease:100195. ISSN 2426-0266 (Online) (doi:10.1016/j.tjpad.2025.100195)